Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting
Matteo Puccetti, Marilena Pariano, Giorgia Renga, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1601-1601
Open Access | Times Cited: 20

Showing 20 citing articles:

Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite
Giorgia Renga, Emilia Nunzi, Marilena Pariano, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003725-e003725
Open Access | Times Cited: 78
DNA hydrogels and nanogels for diagnostics, therapeutics, and theragnostics of various cancers
Iman Zare, Reza Taheri‐Ledari, Farhad Esmailzadeh, et al.
Nanoscale (2023) Vol. 15, Iss. 26, pp. 10882-10903
Closed Access | Times Cited: 27
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis
Fiorella D’Onofrio, Giorgia Renga, Matteo Puccetti, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1622-1622
Open Access | Times Cited: 40
Ultrasonic energy for construction of bioactive heterocycles
Omkar Kamble, Rana Chatterjee, Ramababu Dandela, et al.
Tetrahedron (2022) Vol. 120, pp. 132893-132893
Closed Access | Times Cited: 24
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches
Lindsey Williams, Shijie Cao
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108605-108605
Closed Access | Times Cited: 5
Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
Aniello Meoli, Olaf Eickmeier, Giovanna Pisi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12421-12421
Open Access | Times Cited: 15
Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis
Chang-E Yang, Yanni Wang, Meng-Ru Hua, et al.
Ageing Research Reviews (2022) Vol. 79, pp. 101662-101662
Closed Access | Times Cited: 14
Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems
Matteo Puccetti, Marilena Pariano, Paulina Wojtylo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 506-506
Open Access | Times Cited: 7
Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection
Matteo Puccetti, Larissa Gomes dos Reis, Marilena Pariano, et al.
International Journal of Pharmaceutics (2021) Vol. 607, pp. 121004-121004
Closed Access | Times Cited: 15
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
Matteo Puccetti, Marilena Pariano, Claudio Costantini, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 336-336
Open Access | Times Cited: 10
Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?
Matteo Puccetti, Aurélie Schoubben, Stefano Giovagnoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2218-2218
Open Access | Times Cited: 5
The effectiveness of EM4 and Local Micro-organisms (LOM) Activators in Organic Waste Processing in Brikama Market West Coast Region, The Gambia
Babucarr Jassey, Syafrudin Syafrudin, Badrus Zaman, et al.
IOP Conference Series Earth and Environmental Science (2022) Vol. 1098, Iss. 1, pp. 012010-012010
Open Access | Times Cited: 6
5-Fluorouracil-Immobilized Hyaluronic Acid Hydrogel Arrays on an Electrospun Bilayer Membrane as a Drug Patch
Jieun Lee, Seung-Min Lee, Chang-Beom Kim, et al.
Bioengineering (2022) Vol. 9, Iss. 12, pp. 742-742
Open Access | Times Cited: 5
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study
Barbara Cellini, Gioena Pampalone, Emidio Camaioni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis
Marilena Pariano, Matteo Puccetti, Claudia Stincardini, et al.
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 68, Iss. 3, pp. 288-301
Closed Access | Times Cited: 4
Postbiotics-peptidoglycan, lipoteichoic acid, exopolysaccharides, surface layer protein and pili proteins—Structure, activity in wounds and their delivery systems
Wang Pu, Shuxin Wang, Donghui Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133195-133195
Closed Access
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis
Marilena Pariano, Anna Gidari, Claudia Stincardini, et al.
Journal of Fungi (2024) Vol. 10, Iss. 7, pp. 510-510
Open Access
Unlocking the AhR Therapeutic Potential for Cystic Fibrosis With an Integrated Mucosal Platform for Drug Screening
Lorenzo Sardelli, Enrica Frasca, Valentina Olga Garbero, et al.
Advanced Therapeutics (2024)
Open Access
Tracing the path of Quorum sensing molecules in cystic fibrosis mucus in a biomimetic in vitro permeability platform
Olga Valentina Garbero, Lorenzo Sardelli, Cosmin Butnarasu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Indole-3-Aldehyde alleviates lung inflammation in COPD through activating Aryl Hydrocarbon Receptor to inhibit HDACs/NF-κB/NLRP3 signaling pathways
Pengtao Wang, Wei Tao, Qiujie Li, et al.
Journal of Molecular Medicine (2024)
Open Access
Page 1

Scroll to top